Impact of Size and Location of Metastases on Early Tumor Shrinkage and Depth of Response in Patients With Metastatic Colorectal Cancer: Subgroup Findings of the Randomized, Open-Label Phase 3 Trial FIRE-3/AIO KRK-0306-Reference-Cited by-同舟云学术

Impact of Size and Location of Metastases on Early Tumor Shrinkage and Depth of Response in Patients With Metastatic Colorectal Cancer: Subgroup Findings of the Randomized, Open-Label Phase 3 Trial FIRE-3/AIO KRK-0306

Published:2020-12 Issue:4 Volume:19 Page:291-300.e5
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Froelich Matthias F.^ORCID,Petersen Elina L.^ORCID,Heinemann Volker,Nörenberg Dominik,Hesse Nina,Gesenhues Alena B.^ORCID,Modest Dominik P.,Sommer Wieland H.,Hofmann Felix O.,Stintzing Sebastian,Holch Julian W.^ORCID

Funder

Merck KGaA

Pfizer

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference36 articles.

1. Global cancer incidence and mortality rates and trends—an update;Torre;Cancer Epidemiol Biomarkers Prev,2016

2. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

3. Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands;Elferink;Int J Colorectal Dis,2015

4. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases;van der Geest;Clin Exp Metastasis,2015

5. Cancer treatment and survivorship statistics, 2014;DeSantis;CA Cancer J Clin,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment outcome comparisons of first‐line targeted therapy in patients with KRAS wild‐type metastatic colorectal cancer: A nationwide database study;Cancer Medicine;2023-06-16

2. Depth of response of induction therapy and consecutive maintenance treatment in patients with RAS wild-type metastatic colorectal cancer: An analysis of the PanaMa trial (AIO KRK 0212);European Journal of Cancer;2023-01

3. The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results;The Oncologist;2022-08-10

4. The Potential and Emerging Role of Quantitative Imaging Biomarkers for Cancer Characterization;Cancers;2022-07-09

5. Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial;BMC Cancer;2022-06-28